Page last updated: 2024-11-01

nicardipine and Facies

nicardipine has been researched along with Facies in 1 studies

Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.

Facies: The appearance of the face that is often characteristic of a disease or pathological condition, as the elfin facies of WILLIAMS SYNDROME or the mongoloid facies of DOWN SYNDROME. (Random House Unabridged Dictionary, 2d ed)

Research Excerpts

ExcerptRelevanceReference
"We have now performed behavioral testing in groups of 10 male Tcf4(± ) PTHS mice dosing by oral gavage at 3 mg/kg once a day for 3 weeks using standard methods to assess sociability, nesting, fear conditioning, self-grooming, open field and test of force."1.56Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Na ( Davidow, A; Ekins, S; Puhl, AC, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ekins, S1
Puhl, AC1
Davidow, A1

Other Studies

1 other study available for nicardipine and Facies

ArticleYear
Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Na
    Pharmaceutical research, 2020, Jun-11, Volume: 37, Issue:7

    Topics: Animals; Behavior Control; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Disease Mod

2020